Back to search

Article

Review or Updates on the clinical pharmacokinetics of levetiracetam

2024-12-28

Abstract excerpt

Epilepsy is one of the five major neuropsychiatric disorders worldwide, primarily due to its high disability and mortality rates. Antiseizure medications (ASMs) are the first-line treatment for primary epilepsy. Levetiracetam (LEV), a broad-spectrum second ASM, has been approved for the treatment of focal seizures, as well as adjunctive therapy for myoclonic seizures and primary generalized tonic-clonic seizures....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
17a9a666-0046-56c6-9b87-91733d92335d
DOI
10.22541/au.173536956.69101789/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Review or Updates on the clinical pharmacokinetics of levetiracetamDOI 10.22541/au.173536956.69101789/v1
Select a neighboring publication to make it the new centre.